The global Biotherapeutics Cell Line Development Market exhibited a substantial growth trajectory, attaining a size of USD 5.0 Billion in 2022, and it is projected to surge exponentially, reaching an impressive USD 17.59 Billion by 2032. The market is anticipated to sustain a commendable compound annual growth rate (CAGR) of 15% throughout the forecast period. This remarkable expansion can be...